Effi cacy and safety of tofacitinib as monotherapy in japanese patients with active rheumatoid arthritis: A 12-week, randomized, phase 2 study

Yoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka, Hiroyuki Nakamura, Shigeyuki Toyoizumi, Samuel Zwillich

Research output: Contribution to journalArticle

66 Citations (Scopus)

Fingerprint Dive into the research topics of 'Effi cacy and safety of tofacitinib as monotherapy in japanese patients with active rheumatoid arthritis: A 12-week, randomized, phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences